| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 10/12/2004 | US6802204 Arrangement for improved water-oil ratio measurements |
| 10/12/2004 | CA2300097C Liver function test |
| 10/12/2004 | CA2296608C Densitometer, test piece for the densitometer, biosensor system, and method for forming terminal of the test piece |
| 10/12/2004 | CA2287481C Process for determining a tissue composition characteristic of an animal |
| 10/12/2004 | CA2238763C Article for collecting and transporting a sample to be analyzed and procedure for determining an analyte |
| 10/12/2004 | CA2147337C Reagent for analyzing leukocytes and a method for classifying leukocytes |
| 10/12/2004 | CA2143957C Method and apparatus for sampling fluids |
| 10/11/2004 | CA2461106A1 Compositions and methods for genetic analysis of polycystic kidney disease |
| 10/07/2004 | WO2004086281A1 Method for comparing proteomes |
| 10/07/2004 | WO2004086053A1 Method for the detection of a pathogenic form of a prion protein |
| 10/07/2004 | WO2004086052A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a2b (adora2b) |
| 10/07/2004 | WO2004086051A1 Test system for discovering active ingredients against prion-induced illnesses and active ingredients for preventing and treating said illnesses |
| 10/07/2004 | WO2004086050A2 Labelling agents for mass spectrometry comprising tertiary amines |
| 10/07/2004 | WO2004086049A1 A homogeneous luminescence energy transfer bioassay |
| 10/07/2004 | WO2004086048A1 Diagnosis of advanced cancer |
| 10/07/2004 | WO2004086047A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a1 (adora1) |
| 10/07/2004 | WO2004086046A1 Immobilization method and kit therefor |
| 10/07/2004 | WO2004086045A1 Method of measuring platelet-derived microvesicles (pmv) using a time-resolved fluorescence immunoassay (tr-fia) |
| 10/07/2004 | WO2004086044A1 Sensor for detecting an analyte using silver nanoparticles |
| 10/07/2004 | WO2004086043A1 Prediction and detection of wound infection |
| 10/07/2004 | WO2004086042A1 Multiple-channel test device, method for producing the same and use thereof |
| 10/07/2004 | WO2004086041A2 Universal readout for target indentification using biological microarrays |
| 10/07/2004 | WO2004086040A1 Latex reagent for adiponectin analysis and method of adiponectin analysis |
| 10/07/2004 | WO2004086039A2 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | WO2004086038A2 A method for screening compounds having the capacity to control tumor cell invasion or metastasis using constitutively active akt |
| 10/07/2004 | WO2004086037A1 Test paper and porous membrane |
| 10/07/2004 | WO2004086036A1 Method of screening substance interacting with abc protein |
| 10/07/2004 | WO2004086034A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor adenosine a3(adora3) |
| 10/07/2004 | WO2004086033A2 Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 6(edg6) |
| 10/07/2004 | WO2004086032A1 Pulp production finishing line quality sensor |
| 10/07/2004 | WO2004086031A2 Bayesian model for the prognosis of hepatitis c virus infection |
| 10/07/2004 | WO2004086030A1 Gas sensor module with contactless interface |
| 10/07/2004 | WO2004086027A2 Mechanical resonator |
| 10/07/2004 | WO2004086026A2 Method for testing prestressed concrete pipes |
| 10/07/2004 | WO2004086024A1 Oxygen analyzer with calibration and blow-back |
| 10/07/2004 | WO2004086021A2 Apparatus for analyzing mixtures of gases |
| 10/07/2004 | WO2004086020A2 Application specific integrated circuitry for controlling analysis of a fluid |
| 10/07/2004 | WO2004086019A1 Method for determining the fire performance of materials |
| 10/07/2004 | WO2004086006A1 Method and device for determining the solid content in a suspension |
| 10/07/2004 | WO2004085999A1 Tissue punching device |
| 10/07/2004 | WO2004085996A2 Biomarkers for longevity and disease and uses thereof |
| 10/07/2004 | WO2004085995A2 Analyte concentration detection devices and methods |
| 10/07/2004 | WO2004085994A2 Erythrocyte sedimentation rate (esr) test measurement instrument of unitary design and method of using the same |
| 10/07/2004 | WO2004085989A2 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics |
| 10/07/2004 | WO2004085683A2 Method for early carcinoma detection and a test kit for carrying our said method |
| 10/07/2004 | WO2004085680A1 Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence |
| 10/07/2004 | WO2004085676A1 In vitro method to detect bladder transitional cell carcinoma |
| 10/07/2004 | WO2004085673A2 Compositions and methods of using hexokinase v |
| 10/07/2004 | WO2004085669A2 Identification and quantification of microbial species in a sample |
| 10/07/2004 | WO2004085668A2 Self-contained assay device for rapid detection of biohazardous agents |
| 10/07/2004 | WO2004085642A1 Arthritis-associated gene and use thereof in examining arthritis |
| 10/07/2004 | WO2004085621A2 Gene expression in breast cancer |
| 10/07/2004 | WO2004085618A2 Method of screening for target ligands |
| 10/07/2004 | WO2004085611A2 Model for mutually exclusive domain folding molecular switch |
| 10/07/2004 | WO2004085546A1 Method of enhancing fluorescence |
| 10/07/2004 | WO2004085539A2 Cyanine dye labelling reagents with meso-substitution |
| 10/07/2004 | WO2004085480A2 Process and composition for assaying carbohydrates |
| 10/07/2004 | WO2004085463A2 Methods of unnatural amino acid incorporation in proteins in mammalian cells |
| 10/07/2004 | WO2004085433A2 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 10/07/2004 | WO2004085049A2 Preparation and application of encoded bead aggregates in combinatorial chemistry |
| 10/07/2004 | WO2004085046A2 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds |
| 10/07/2004 | WO2004084953A1 Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084943A1 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 10/07/2004 | WO2004084942A2 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | WO2004084930A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 10/07/2004 | WO2004084893A1 Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53 |
| 10/07/2004 | WO2004084841A2 Novel anti-feline albumin antibodies and methods of detecting early renal disease |
| 10/07/2004 | WO2004084838A2 Identification, quantification, and characterization of t cells and t cell antigens |
| 10/07/2004 | WO2004084835A2 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 10/07/2004 | WO2004084832A2 Measurement of estrogen activity in plants and a composition therefrom |
| 10/07/2004 | WO2004084830A2 Method for treating alzheimer’s dementia |
| 10/07/2004 | WO2004084823A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
| 10/07/2004 | WO2004084818A2 Measurement of estrogen activity in plants and a composition therefrom |
| 10/07/2004 | WO2004084811A2 Crystals and structures of epidermal growth factor receptor kinase domain |
| 10/07/2004 | WO2004084808A2 Animal with surgically modified gastrointestinal tract and method for study of weight reduction |
| 10/07/2004 | WO2004084802A2 Glycoconjugate sensors |
| 10/07/2004 | WO2004084800A2 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use |
| 10/07/2004 | WO2004084797A2 Type 2 diabetes mellitus-associated gene and utilization of the same |
| 10/07/2004 | WO2004084711A2 Methods of detecting neurological disorders |
| 10/07/2004 | WO2004077063A3 Method involving plasma membrane localisation of oxysterol biding proteins |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2004072223A3 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase |
| 10/07/2004 | WO2004072220A3 Process of sex selection of mammal spermatozoa and method to control quality of frozen sexed semen doses |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004064714A3 Animal model for obesity independently of insulin resistance |
| 10/07/2004 | WO2004061407A9 Glycopeptide identification and analysis |
| 10/07/2004 | WO2004057342A3 Method for enhanced accuracy in predicting the elution times of peptides using liquid separations or chromatography |
| 10/07/2004 | WO2004057328A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38) |
| 10/07/2004 | WO2004055646A3 Method for profiling and identifying persons by using data samples |
| 10/07/2004 | WO2004053105A9 Direct snp detection with unamplified dna |
| 10/07/2004 | WO2004048600A3 Diagnostic tests and methods for diagnosing inflammatory bowel disease |
| 10/07/2004 | WO2004046715A3 Marker substances and the use of the same in diagnostic methods |
| 10/07/2004 | WO2004046314A3 Methods for detecting asymmetric dimethylarginine in a biological sample |
| 10/07/2004 | WO2004045517A3 Method for the diagnosis and treatment of vascular disease |
| 10/07/2004 | WO2004043223A3 Compositions and methods for the diagnosis and treatment of sepsis |
| 10/07/2004 | WO2004042364A3 Assay device, system and method |
| 10/07/2004 | WO2004034208A3 System and method for identifying a food event, tracking the food product, and assessing risks and costs associated with intervention |
| 10/07/2004 | WO2004033640A3 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 10/07/2004 | WO2004026427A3 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |